KalVista Pharmaceuticals Inc (KALV)
9.33
+0.37
(+4.13%)
USD |
NASDAQ |
Nov 21, 16:00
9.33
0.00 (0.00%)
After-Hours: 17:34
KalVista Pharmaceuticals Price to Book Value: 2.657 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.552 |
| November 19, 2024 | 2.578 |
| November 18, 2024 | 2.649 |
| November 15, 2024 | 2.703 |
| November 14, 2024 | 2.791 |
| November 13, 2024 | 2.976 |
| November 12, 2024 | 3.039 |
| November 11, 2024 | 3.159 |
| November 08, 2024 | 3.250 |
| November 07, 2024 | 3.184 |
| November 06, 2024 | 3.250 |
| November 05, 2024 | 3.204 |
| November 04, 2024 | 2.909 |
| November 01, 2024 | 2.654 |
| October 31, 2024 | 2.568 |
| October 30, 2024 | 2.801 |
| October 29, 2024 | 2.949 |
| October 28, 2024 | 3.024 |
| October 25, 2024 | 2.921 |
| October 24, 2024 | 3.019 |
| October 23, 2024 | 3.004 |
| October 22, 2024 | 3.089 |
| October 21, 2024 | 3.081 |
| October 18, 2024 | 3.126 |
| October 17, 2024 | 3.024 |
| Date | Value |
|---|---|
| October 16, 2024 | 3.084 |
| October 15, 2024 | 2.996 |
| October 14, 2024 | 2.931 |
| October 11, 2024 | 2.909 |
| October 10, 2024 | 2.748 |
| October 09, 2024 | 2.811 |
| October 08, 2024 | 2.804 |
| October 07, 2024 | 2.821 |
| October 04, 2024 | 2.841 |
| October 03, 2024 | 2.886 |
| October 02, 2024 | 2.961 |
| October 01, 2024 | 2.848 |
| September 30, 2024 | 2.896 |
| September 27, 2024 | 3.086 |
| September 26, 2024 | 2.501 |
| September 25, 2024 | 2.366 |
| September 24, 2024 | 2.413 |
| September 23, 2024 | 2.446 |
| September 20, 2024 | 2.624 |
| September 19, 2024 | 2.751 |
| September 18, 2024 | 2.674 |
| September 17, 2024 | 2.644 |
| September 16, 2024 | 2.694 |
| September 13, 2024 | 2.786 |
| September 12, 2024 | 2.616 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6279
Minimum
Oct 19 2022
17.40
Maximum
Feb 16 2021
2.973
Average
2.380
Median
Oct 11 2023
Price to Book Value Benchmarks
| Nuwellis Inc | 1.693 |
| Perspective Therapeutics Inc | 0.6153 |
| Electromed Inc | 5.682 |
| Xtant Medical Holdings Inc | 1.249 |
| Myomo Inc | 15.56 |
Price to Book Value Related Metrics
| PS Ratio | 29.22 |
| PEG Ratio | -0.3487 |
| Price | 9.33 |
| Earnings Yield | -38.37% |
| Market Cap | 459.18M |
| PEGY Ratio | -0.3487 |